Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bulbo-Spinal Atrophy, X-Linked × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 197 Neoplasm Metastasis 14 Neoplasms 12 Carcinoma, Intraductal, Noninfiltrating 8 Advanced Breast Cancer 7 Breast Neoplasms, Male 6 Breast Diseases 5 Breast Carcinoma In Situ 5 Triple Negative Breast Neoplasms 4 Endometrial Neoplasms 4 Arthralgia 4 Ovarian Neoplasms 3 Breast Cancer Metastatic 3 Recurrence 2 Osteoporosis 2 Obesity 2 Neoplasms by Site 2 Multiple Endocrine Neoplasia Type 1 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Patient Compliance 1 Pancreatic Neoplasms 1

Interventions

bicalutamide 4 exemestane 2 enzalutamide 2 darolutamide 2 abiraterone 2 pembrolizumab 1 ostarine 1 nilutamide 1 cabazitaxel 1 apalutamide 1 abemaciclib 1 Vorinostat 1 Triptorelin Pamoate 1 Tamoxifen 1 Prophylactic Mastectomy 1 Prednisolone 1 Mifepristone 1 Letrozole 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Goserelin 1 Doxorubicin 1 Docetaxel 1 Dasatinib 1 Cisplatin 1 CP protocol 1 Aromatase Inhibitors 1 Antiemetics 1 Anastrozole 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02910050 2017-12-22

BETTER

Sun Yat-sen University

Phase 2 Unknown

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon ⚡